shigella flexneri 2a invaplex 50
Vaccineexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2004 (NCT00082069)
Timeline
2000s
- Jan 1, 2004
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Shigella flexneriImmunity, active
Shigella flexneri immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- shigella flexneri 2a invaplex 50
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02445963 | Phase 1 | Oct 1, 2015 | United States Army, United States Navy |
| NCT01509846 | Phase 1 | Mar 1, 2011 | Johns Hopkins University, PATH |
| NCT00082069 | Phase 1 | Apr 1, 2004 | United States Army, United States Navy |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| United States Army | Government | 2 | 2 | 1 | 2004 |
| United States Navy | Government | 2 | 0 | 1 | 2004 |
| Johns Hopkins University | Academic/Hospital | 1 | 0 | 1 | 2011 |
| PATH | Academic/Hospital | 1 | 1 | 1 | 2011 |
4 organizations
Page 1 / 1